BioNexus Gene Lab (BGLC) vs Personalis (PSNL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Personalis is the larger company by market cap ($1.71 billion vs $3.9 million), about 434.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BGLC | PSNL |
|---|---|---|
| Share price | $1.34 | $16.00 |
| Market cap | $3.93M | $1.71B |
| 1-day change | +6.77% | -0.19% |
| YTD return | — | +101.01% |
| 1-year return | — | +111.36% |
| 5-year return | — | -19.76% |
| EPS (TTM) | $-1.26 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $18.89 |
| 52-week low | $1.07 | $4.96 |
| Distance from 52-week high | -77.24% | -15.30% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | -5.19% |
| Average volume | 10.82K | 3.60M |
| Shares outstanding | 2.93M | 106.80M |
| Employees | — | 259 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Personalis is about 434.7 times larger than BioNexus Gene Lab by market value ($1.71B vs $3.93M).
About Personalis
PSNL stock →Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Health Care · Medical Specialities · 259 employees
BGLC vs PSNL FAQ
Which is bigger, BioNexus Gene Lab or Personalis?
Personalis (PSNL) is larger, with a market capitalization of $1.71B compared with $3.93M for BioNexus Gene Lab (BGLC).
Are BioNexus Gene Lab and Personalis in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.